Anti-CD11a treatment for psoriasis concurrently increases circulating T-cells and decreases plaque T-cells, consistent with inhibition of cutaneous T-cell trafficking
Krueger
J
Gottlieb
A
Miller
B
Dedrick
R
Garovoy
M
Walicke
P